Trading Day Review: Brainstorm Cell Therapeutics, Inc. (BCLI) Loses Momentum, Closing at 0.31

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) closed at $0.31 in the last session, down -2.98% from day before closing price of $0.32. In other words, the price has decreased by -$2.98 from its previous closing price. On the day, 0.15 million shares were traded. BCLI stock price reached its highest trading level at $0.3219 during the session, while it also had its lowest trading level at $0.2998.

Ratios:

We take a closer look at BCLI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.50 and its Current Ratio is at 0.50.

Maxim Group reiterated its Buy rating for the stock on December 19, 2016, while the target price for the stock was revised from $5 to $6.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 19 ’24 when Dagher Ibrahim B. sold 63,000 shares for $0.35 per share. The transaction valued at 22,069 led to the insider holds 0 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCLI now has a Market Capitalization of 24637834 and an Enterprise Value of 22130834.

Stock Price History:

Over the past 52 weeks, BCLI has reached a high of $1.79, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is -10.59%, while the 200-Day Moving Average is calculated to be -18.71%.

Shares Statistics:

According to the various share statistics, BCLI traded on average about 556.32K shares per day over the past 3-months and 282310 shares per day over the past 10 days. A total of 79.73M shares are outstanding, with a floating share count of 72.43M. Insiders hold about 9.15% of the company’s shares, while institutions hold 15.32% stake in the company. Shares short for BCLI as of 1723680000 were 1617894 with a Short Ratio of 2.91, compared to 1721001600 on 1080538. Therefore, it implies a Short% of Shares Outstanding of 1617894 and a Short% of Float of 2.15.

Most Popular